These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 22945)

  • 1. Marrow grafts between DLA-identical and homozygous unrelated dogs: evidence for an additional locus involved in graft-versus-host disease.
    Storb R; Weiden PL; Graham TC; Lerner KG; Thomas ED
    Transplantation; 1977 Sep; 24(3):165-74. PubMed ID: 22945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Marrow grafts between phenotypically DLA-identical and haploidentical unrelated dogs: additional antigens controlling engraftment are not detected by cell-mediated lympholysis.
    Deeg HJ; Storb R; Raff RF; Weiden PL; DeRose S; Thomas ED
    Transplantation; 1982 Jan; 33(1):17-21. PubMed ID: 7039018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific tolerance and immunocompetence in haploidentical, but not in completely allogeneic, canine chimeras treated with methotrexate and cyclosporine.
    Deeg HJ; Severns E; Raff RF; Sale GE; Storb R
    Transplantation; 1987 Nov; 44(5):621-32. PubMed ID: 2961110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FK-506 and methotrexate prevent graft-versus-host disease in dogs given 9.2 Gy total body irradiation and marrow grafts from unrelated dog leukocyte antigen-nonidentical donors.
    Storb R; Raff RF; Appelbaum FR; Deeg HJ; Fitzsimmons W; Graham TC; Pepe M; Pettinger M; Sale G; van der Jagt R
    Transplantation; 1993 Oct; 56(4):800-7. PubMed ID: 7692635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Marrow graft studies in dogs: factors influencing resistance to engraftment and graft-versus-host disease.
    Deeg HJ; Storb R; Thomas ED
    Surv Immunol Res; 1982; 1(2):148-54. PubMed ID: 6764839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclosporin A and methotrexate in canine marrow transplantation: engraftment, graft-versus-host disease, and induction of intolerance.
    Deeg HJ; Storb R; Weiden PL; Raff RF; Sale GE; Atkinson K; Graham TC; Thomas ED
    Transplantation; 1982 Jul; 34(1):30-5. PubMed ID: 6750877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Marrow grafts between canine litter-mates homozygous or heterozygous for lymphocyte-defined histocompatibility antigens.
    Storb R; Weiden PL; Schroeder ML; Graham TC; Lerner KG; Thomas ED
    Transplantation; 1976 Apr; 21(4):299-306. PubMed ID: 7864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tolerance in DLA-haploidentical canine littermates following CD6-depleted marrow transplantation and donor lymphocyte transfusion.
    Zorn J; Herber M; Schwamberger S; Panzer W; Adler H; Kolb HJ
    Exp Hematol; 2009 Aug; 37(8):998-1006. PubMed ID: 19446000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An anti-CD44 antibody does not enhance engraftment of DLA-identical marrow after low-dose total body irradiation.
    Sandmaier BM; Storb R; Liu Y; Santos EB; Bryant E; Schuening FG; Deeg HJ; Seidel K; Graham T
    Transpl Immunol; 1996 Dec; 4(4):271-4. PubMed ID: 8972556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 'Resistance' to unrelated, DLA-nonidentical canine marrow grafts is unrestricted by the major histocompatibility complex.
    Raff RF; Sandmaier BM; Graham T; Loughran TP; Pettinger M; Storb R
    Exp Hematol; 1994 Aug; 22(9):893-7. PubMed ID: 8062888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tacrolimus (FK506) and methotrexate regimens to prevent graft-versus-host disease after unrelated dog leukocyte antigen (DLA) nonidentical marrow transplantation.
    Yu C; Storb R; Deeg HJ; Graham TC; Scheuning FG; Huss R; Seidel K; Fitzsimmons WE
    Bone Marrow Transplant; 1996 Apr; 17(4):649-53. PubMed ID: 8722370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engraftment of DLA-nonidentical unrelated canine marrow after high-dose fractionated total body irradiation.
    Deeg HJ; Storb R; Shulman HM; Weiden PL; Graham TC; Thomas ED
    Transplantation; 1982 Apr; 33(4):443-6. PubMed ID: 7041371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathology of acute graft-versus-host disease in the dog. An autopsy study of ninety-five dogs.
    Kolb H; Sale GE; Lerner KG; Storb R; Thomas ED
    Am J Pathol; 1979 Aug; 96(2):581-94. PubMed ID: 38670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recipient-specific donor cytotoxic T lymphocytes enhance engraftment of unrelated, DLA non-identical canine marrow.
    Schwarzinger I; Raff RF; Flowers M; Niederwieser D; Graham T; Shulman H; Appelbaum FR; Schuening F; Storb R
    Bone Marrow Transplant; 1994 Mar; 13(3):303-9. PubMed ID: 8199572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adoptive immunotherapy against allogeneic kidney grafts in dogs with stable hematopoietic trichimerism.
    Graves SS; Hogan WJ; Kuhr C; Diaconescu R; Harkey M; Sale GE; Stone B; Georges GE; Storb R
    Biol Blood Marrow Transplant; 2008 Nov; 14(11):1201-8. PubMed ID: 18940673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined immunosuppression with cyclosporine and methotrexate in dogs given bone marrow grafts from DLA-haploidentical littermates.
    Deeg HJ; Storb R; Appelbaum FR; Kennedy MS; Graham TC; Thomas ED
    Transplantation; 1984 Jan; 37(1):62-5. PubMed ID: 6364490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gamma-irradiation of pretransplant blood transfusions from unrelated donors prevents sensitization to minor histocompatibility antigens on dog leukocyte antigen-identical canine marrow grafts.
    Bean MA; Graham T; Appelbaum FR; Deeg HJ; Schuening F; Sale GE; Storb R
    Transplantation; 1994 Feb; 57(3):423-6. PubMed ID: 8108879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of treatment with DLA-identical or unrelated mesenchymal stromal cells in DLA-identical canine bone marrow transplantation.
    Kornblit B; Leisenring WM; Santos EB; Storb R; Sandmaier BM
    Chimerism; 2013; 4(3):95-101. PubMed ID: 23723082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Marrow grafts between canine siblings matched by serotyping and mixed leukocyte culture.
    Storb R; Rudolph RH; Thomas ED
    J Clin Invest; 1971 Jun; 50(6):1272-5. PubMed ID: 4931083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of recombinant canine stem cell factor, a c-kit ligand, on hematopoietic recovery after DLA-identical littermate marrow transplants in dogs.
    Schuening FG; von Kalle C; Kiem HP; Appelbaum FR; Deeg HJ; Pepe M; Gooley T; Graham TC; Hackman RC; Storb R
    Exp Hematol; 1997 Nov; 25(12):1240-5. PubMed ID: 9357967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.